Status:

COMPLETED

Efficacy and Safety of Calcipotriol Plus Betamethasone Gel in the Treatment of Scalp Psoriasis

Lead Sponsor:

LEO Pharma

Conditions:

Psoriasis of Scalp

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of this study is to evaluate whether once daily treatment for up to 8 weeks of calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) gel is safe and more effective than betam...

Eligibility Criteria

Inclusion

  • Main
  • Scalp psoriasis amenable to topical treatment
  • Psoriasis vulgaris on trunk and/or limbs
  • Extent of scalp psoriasis involving more than 10% of the total scalp area
  • Disease severity on the scalp graded as mild or worse by the investigator
  • Consenting out-patients of 18 years or above
  • Main

Exclusion

  • PUVA or Grenz ray therapy within 4 weeks prior to randomisation
  • UVB therapy within 2 weeks prior to randomisation
  • Systematic treatment with biological therapies, with a possible effect on scalp psoriasis within 6 months prior to randomisation
  • Systemic treatment with all other therapies than biologicals, with a possible effect on scalp psoriasis (e.g., corticosteroids, vitamin D analogues, retinoids, immunosuppressants) within 4 weeks prior to randomisation
  • Any topical treatment of the scalp (except for medicated shampoos and emollients) within 2 weeks prior to randomisation
  • Topical treatment of the face, trunk and/or limbs with very potent WHO group IV corticosteroids within 2 weeks prior to randomisation
  • Current diagnosis of erythrodermic, exfoliative or pustular psoriasis

Key Trial Info

Start Date :

November 1 2004

Trial Type :

INTERVENTIONAL

End Date :

September 1 2005

Estimated Enrollment :

1485 Patients enrolled

Trial Details

Trial ID

NCT00216827

Start Date

November 1 2004

End Date

September 1 2005

Last Update

February 24 2025

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

FRCPC, Centre de Recherche Dermatologique du Quebec Metropolitain

Québec, Canada, G1V 4X7

2

Roskilde Hospital, Division of Dermatology

Roskilde, Denmark, 4000

3

Hôpital de l'Archet, Service de Dermatologie

Nice, France, 06202

4

Hudlegekontoret

Sandvika, Norway, 1338